Patient Selection and Practical Implementation of Renal Denervation in Patients with Treatment-Resistant Hypertension

Published: 12 June 2020

  • Views:

    Views Icon 38
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This case-based course brings together opinion leaders engaged in RDN to review the evidence, discuss trial data, and practical aspects around patient selection and management of treatment-resistant hypertension.

 

EBAC Accreditation

This programme was funded by an unrestricted educational grant from Medtronic.

More from this programme

Part 1

Patients with Poor Adherence

Part 2

Patients with Hypertension with High Cardiovascular Risk

Part 3

Uncontrolled Hypertension despite Medication

Faculty Biographies

Andrew SP Sharp

Andrew SP Sharp

Consultant Cardiologist

Prof Andrew Sharp qualified from Edinburgh Medical School in 1998. He conducted his senior clinical training at Imperial College Hospitals and San Raffaele Hospital, Milan, before being appointed in 2011 as a Consultant Cardiologist and Honorary Senior Lecturer at the Royal Devon and Exeter Hospital and University of Exeter. Professor Sharp was awarded an MD postgraduate research degree for his work on the hypertensive heart whilst at Imperial College and now leads a growing research programme at the Royal Devon and Exeter Hospital in the fields of hypertension, renal denervation, ischaemic heart disease, intra-coronary imaging, coronary physiology, pulmonary embolus and aortic valve disease.

View full profile
Atul Pathak

Atul Pathak

Professor

Dr Atul Pathak is a Pharmacologist and Cardiologist. He is leading a clinical research team focusing on cardiovascular pathophysiology and clinical pharmacology and is affiliated to INSERM (National Institute of Medical Research).

Dr Pathak has been awarded by the ESC (Young Investigator Award), by the British Pharmacological Society and the French Society of Cardiology. He is also member of the French Association of Pharmacologists, the French Society of Hypertension and Cardiology, the American Society for Heart Failure. He is elected President of the Cardiovascular Pharmacology Working Group of the French Society of Cardiology. He has both academic and institutional commitments, among them participation at advisory board at AFSSAPS (French FDA) and HAS for the review of clinical trials protocol, assessment of benefit /risk ratio of drugs (marketed or under development) and medico-economic issues (regarding lipid or blood pressure lowering drugs).

View full profile
Roland E Schmieder

Roland E Schmieder

Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension

Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Professor Schmieder is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the University…

View full profile
Stefano Taddei

Stefano Taddei

Professor Stefano Taddei works at the Department of Medicine at the University of Pisa, Italy. He currently serves as a Fellow of the European Society of Cardiology, the European Society of Hypertension, and the International Society of Hypertension.

View full profile